Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
- USD | -.--% | +0.08% | +0.24% |
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
Colin S. Dunn
CEO | Chief Executive Officer | - | - |
David Smith
DFI | Director of Finance/CFO | 58 | - |
Maria Pia Muniz
COO | Chief Operating Officer | - | 02-12-31 |
Kalust Ucar
CTO | Chief Tech/Sci/R&D Officer | - | 14-03-31 |
Stephen Minger
PRN | Corporate Officer/Principal | - | - |
Bobbie L. King
SEC | Corporate Secretary | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Colin S. Dunn
CEO | Chief Executive Officer | - | - |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 13,657,206 | 12,860,956 ( 94.17 %) | 0 | 94.17 % |
Company contact information
Charles River Laboratories Cell Solutions, Inc.
8500 Balboa Boulevard Suite 130
91325, Northridge
+
http://www.hemacare.com/Sector
1st Jan change | Capi. | |
---|---|---|
+0.24% | 346M | |
+14.35% | 81.84B | |
-30.37% | 70.69B | |
+9.37% | 29.03B | |
-11.85% | 16.97B | |
-0.36% | 16.83B | |
-1.19% | 15.28B | |
+5.90% | 12.41B | |
+36.32% | 12.26B | |
-4.20% | 11.86B |
- Stock Market
- Equities
- HEMA Stock
- Company HemaCare Corporation